Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Retatrutide is a once-weekly injectable medication currently in development for weight management and metabolic disorders
Small-molecule fluorescent probes have gained increasing attention since the emergence of calcium and zinc probes 13,14
These studies suggest that strategies combining NAD + boosting with inhibitors of NAD + -consuming enzymes could be a promising approach to mitigate axon degeneration
20 This observation emphasizes their potential to promote systemic metabolic health beyond glucose homeostasis and makes GLP-1RAs a more suitable treatment option for T2D patients with a higher risk of cardiovascular disease compared to metformin
Enhancing Patient Recruitment in Niche Markets Through Clinical Trial Outsourcing Explore clinical trial outsourcing and its role in overcoming recruitment challenges in clinical research for small biotech companies
